Skip to main content
Article
Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: A California Cancer Consortium Trial
International Journal of Gynecological Cancer (2007)
  • R. J. Morgan, City of Hope National Medical Center
  • T. W. Synold, City of Hope National Medical Center
  • D. Gandara, University of California, Davis
  • F. Muggia, University of Southern California
  • S. Scudder, University of California, Davis
  • E. Reed, National Institutes of Health
  • K. Margolin, City of Hope National Medical Center
  • J. Raschko, City of Hope National Medical Center
  • L. Leong, City of Hope National Medical Center
  • S. Shibata, City of Hope National Medical Center
  • M. Tetef, City of Hope National Medical Center
  • S. Vasilev, City of Hope National Medical Center
  • K. McGonigle, City of Hope National Medical Center
  • J. Longmate, City of Hope National Medical Center
  • Y. Yen, City of Hope National Medical Center
  • W. Chow, City of Hope National Medical Center
  • G. Somlo, City of Hope National Medical Center
  • M. Carroll, City of Hope National Medical Center
  • J. H. Doroshow, City of Hope National Medical Center
Publication Date
January 1, 2007
DOI
10.1111/j.1525-1438.2007.00787.x
Citation Information
R. J. Morgan, T. W. Synold, D. Gandara, F. Muggia, et al.. "Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: A California Cancer Consortium Trial" International Journal of Gynecological Cancer Vol. 17 Iss. 2 (2007) p. 373 - 378
Available at: http://works.bepress.com/steven-vasilev/8/